Elekta AB (EKTA B) – Pharmaceutical Product Pipeline Analysis and Guide (2017)

Albany, US, 2017-Sep-07 — /EPR Network/ — Market Research Hub (MRH) has included the latest Forecast report titled “Elekta AB (EKTA B) Product Pipeline Analysis 2017”, to its vast database. This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products, and brands. The report also enhances decision-making capabilities and help to create effective counter strategies to gain competitive advantage.

Request Free Sample Report @ http://www.marketresearchhub.com/enquiry.php?type=S&repid=1318782

Elekta AB (Elekta) is a medical technology company that offers image guided and stereotactic clinical solutions, comprehensive information systems and services for the management of brain disorders and improved cancer care. Its major products include Gamma knife and Extend system; stereotactic system; fully integrated stereotactic radiation therapy system; system for volumetric arc modulated therapy (VMAT); image guided radiation therapy (IGRT) systems; advanced digital treatment systems; treatment planning systems; electronic brachy therapy for skin cancer; and automated remote after loading platform. It also offers oncology information systems for radiation oncology and medical oncology, treatment planning software, cancer registry and soft tissue visualization software, among others. Elekta products find applications the treatment of cancer using radio therapy and in diagnosis and treatment of brain disorders in hospitals, academic institutions, and specialist and satellite clinics throughout the world. The company operates in North America, Europe, the Middle East, Africa and Asia-Pacific. Elekta is headquartered in Stockholm, Sweden.

Scope:
– The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
– The report analyzes all pipeline products in development for the company Elekta AB
– The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
– The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
– The report provides detailed description of products in development, technical specification and functions
– The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:
– Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
– Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
– To formulate effective Research & Development strategies
– Develop market-entry and market expansion strategies
– Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
– Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Develop competition strategies by identifying the status and likely launch of the competitors pipeline products through review of the clinical trials, stage and of development, etc
– Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Browse Full Report with TOC @ http://www.marketresearchhub.com/report/elekta-ab-ekta-b-product-pipeline-analysis-2017-update-report.html

Table of Content:

Table of Contents 2
List of Tables 3
List of Figures 3
Elekta AB Company Overview 4
Elekta AB Company Snapshot 4
Elekta AB Pipeline Products and Ongoing Clinical Trials Overview 4
Elekta AB Pipeline Analysis Overview 7
Business Description 7
Elekta AB – Key Facts 7
Elekta AB – Major Products and Services 9
Elekta AB Pipeline Products by Development Stage 12
Elekta AB Ongoing Clinical Trials by Trial Status 14
Elekta AB Pipeline Products Overview 16
Elekta Unity 16
Elekta Unity Product Overview 16
Elekta Unity Clinical Trial 17
Leksell Vantage Stereotactic System 18
Leksell Vantage Stereotactic System Product Overview 18
MOSAIQ Mobile 19
MOSAIQ Mobile Product Overview 19
MR-linac System 20
MR-linac System Product Overview 20
MR-linac System Clinical Trial 21
Next generation Gamma Knife 22
Next generation Gamma Knife Product Overview 22
Elekta AB – Key Competitors 23
Elekta AB – Key Employees 24
Elekta AB – Key Employee Biographies 25
Elekta AB – Locations And Subsidiaries 26

….continue


Make an Enquiry @
 http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1318782

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of pharmaceutical market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients and customers.

Contact Us

90 State Street,

Albany, NY 12207,

United States

Toll Free: 800-998-4852 (US-Canada)

Email: press@marketresearchhub.com

Website: http://www.marketresearchhub.com/

Read Industry News at – https://www.industrynewsanalysis.com/

Matched content

Editor’s pick

Express Press Release Distribution